Aline Schögler1, Oliver Caliaro1, Melanie Brügger2, Blandina I Oliveira Esteves3, Izabela Nita4, Amiq Gazdhar4, Thomas Geiser4, Marco P Alves5. 1. Division of Respiratory Medicine, Department of Paediatrics, University Hospital Bern, Bern, Switzerland. 2. Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland; Institute of Virology and Immunology, Bern, Switzerland; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. 3. Institute of Virology and Immunology, Bern, Switzerland; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. 4. Department of Pulmonary Medicine, University Hospital Bern, Bern, Switzerland; Department of Biomedical Research, University of Bern, Bern, Switzerland. 5. Division of Respiratory Medicine, Department of Paediatrics, University Hospital Bern, Bern, Switzerland; Institute of Virology and Immunology, Bern, Switzerland; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland. Electronic address: marco.alves@vetsuisse.unibe.ch.
Abstract
INTRODUCTION: Rhinovirus (RV) infection is a major cause of cystic fibrosis (CF) lung morbidity with limited therapeutic options. Various diseases involving chronic inflammatory response and infection are associated with endoplasmic reticulum (ER) stress and subsequent activation of the unfolded protein response (UPR), an adaptive response to maintain cellular homeostasis. Recent evidence suggests impaired ER stress response in CF airway epithelial cells, this might be a reason for recurrent viral infection in CF. Therefore, assuming that ER stress inducing drugs have antiviral properties, we evaluated the activation of the UPR by selected ER stress inducers as an approach to control virus replication in the CF bronchial epithelium. METHODS: We assessed the levels of UPR markers, namely the glucose-regulated protein 78 (Grp78) and the C/EBP homologous protein (CHOP), in primary CF and control bronchial epithelial cells and in a CF and control bronchial epithelial cell line before and after infection with RV. The cells were also pretreated with ER stress-inducing drugs and RV replication and shedding was measured by quantitative RT-PCR and by a TCID50 assay, respectively. Cell death was assessed by a lactate dehydrogenate (LDH) activity test in supernatants. RESULTS: We observed a significantly impaired induction of Grp78 and CHOP in CF compare to control cells following RV infection. The ER stress response could be significantly induced in CF cells by pharmacological ER stress inducers Brefeldin A, Tunicamycin, and Thapsigargin. The chemical induction of the UPR pathway prior to RV infection of CF and control cells reduced viral replication and shedding by up to two orders of magnitude and protected cells from RV-induced cell death. CONCLUSION: RV infection causes an impaired activation of the UPR in CF cells. Rescue of the ER stress response by chemical ER stress inducers reduced significantly RV replication in CF cells. Thus, pharmacological modulation of the UPR might represent a strategy to control respiratory virus replication in the CF bronchial epithelium.
INTRODUCTION: Rhinovirus (RV) infection is a major cause of cystic fibrosis (CF) lung morbidity with limited therapeutic options. Various diseases involving chronic inflammatory response and infection are associated with endoplasmic reticulum (ER) stress and subsequent activation of the unfolded protein response (UPR), an adaptive response to maintain cellular homeostasis. Recent evidence suggests impaired ER stress response in CF airway epithelial cells, this might be a reason for recurrent viral infection in CF. Therefore, assuming that ER stress inducing drugs have antiviral properties, we evaluated the activation of the UPR by selected ER stress inducers as an approach to control virus replication in the CF bronchial epithelium. METHODS: We assessed the levels of UPR markers, namely the glucose-regulated protein 78 (Grp78) and the C/EBP homologous protein (CHOP), in primary CF and control bronchial epithelial cells and in a CF and control bronchial epithelial cell line before and after infection with RV. The cells were also pretreated with ER stress-inducing drugs and RV replication and shedding was measured by quantitative RT-PCR and by a TCID50 assay, respectively. Cell death was assessed by a lactate dehydrogenate (LDH) activity test in supernatants. RESULTS: We observed a significantly impaired induction of Grp78 and CHOP in CF compare to control cells following RV infection. The ER stress response could be significantly induced in CF cells by pharmacological ER stress inducers Brefeldin A, Tunicamycin, and Thapsigargin. The chemical induction of the UPR pathway prior to RV infection of CF and control cells reduced viral replication and shedding by up to two orders of magnitude and protected cells from RV-induced cell death. CONCLUSION: RV infection causes an impaired activation of the UPR in CF cells. Rescue of the ER stress response by chemical ER stress inducers reduced significantly RV replication in CF cells. Thus, pharmacological modulation of the UPR might represent a strategy to control respiratory virus replication in the CF bronchial epithelium.
Authors: Yiping Liu; Yury A Bochkov; Jens C Eickhoff; Tianchen Hu; Nicholas A Zumwalde; Jin Wen Tan; Christopher Lopez; Paul S Fichtinger; Thiruchelvi R Reddy; Katherine A Overmyer; Jennifer E Gumperz; Joshua Coon; Sameer K Mathur; James E Gern; Judith A Smith Journal: Am J Respir Cell Mol Biol Date: 2020-06 Impact factor: 6.914
Authors: Brahmchetna Bedi; Kuo-Chuan Lin; Nicholas M Maurice; Zhihong Yuan; Kaiser Bijli; Michael Koval; C Michael Hart; Joanna B Goldberg; Arlene Stecenko; Ruxana T Sadikot Journal: Clin Sci (Lond) Date: 2020-07-31 Impact factor: 6.124
Authors: Talita B Gagliardi; Monty E Goldstein; Daniel Song; Kelsey M Gray; Jae W Jung; Maxinne A Ignacio; Kimberly M Stroka; Gregg A Duncan; Margaret A Scull Journal: PLoS Pathog Date: 2022-01-07 Impact factor: 6.823
Authors: Pasquale Laise; Gideon Bosker; Xiaoyun Sun; Yao Shen; Eugene F Douglass; Charles Karan; Ronald B Realubit; Sergey Pampou; Andrea Califano; Mariano J Alvarez Journal: bioRxiv Date: 2020-05-17
Authors: Kak-Ming Ling; Luke W Garratt; Erin E Gill; Amy H Y Lee; Patricia Agudelo-Romero; Erika N Sutanto; Thomas Iosifidis; Tim Rosenow; Stuart E Turvey; Timo Lassmann; Robert E W Hancock; Anthony Kicic; Stephen M Stick Journal: Front Immunol Date: 2020-07-16 Impact factor: 7.561